In 2020, Michael Hunkapiller earned $5.04M in total compensation at Pacific Biosciences of California, including $582.90K salary and $3.87M in stock. Most recently sold 234,246 shares in Feb 2021. Currently holds stock worth $1.84M. Led Pacific Biosciences of California as CEO for 8 years.
Compensation History
Annual executive compensation data for Michael Hunkapiller, including salary, bonuses, and stock awards.
Year
2020
Total Compensation
$5.04M
Salary
$582.90K
Bonus
$0.00
Other
$582.90K
Salary
$582.90KBoard Justification
The compensation philosophy is designed to attract and retain key executives while aligning their interests with those of stockholders through performance-based incentives.
Bonus
$0.00Board Justification
No bonuses were awarded for 2020 due to his transition out of the CEO role and the lack of a cash incentive plan for the first half of the year.
Other Compensation
$582.90KBoard Justification
Cash severance of $582,900 was paid in connection with his departure from the Company as an employee.
Restricted Stock
Board Justification
150,000 RSUs vested in 2020 as part of his compensation package, subject to continued service until the vesting date.
Performance Metrics
The performance metrics for 2020 were not applicable to Dr. Hunkapiller as he transitioned out of his role as CEO.
Michael Hunkapiller
Ex-CEO of Pacific Biosciences of California
Education
Ph.D. in Chemical Biology from the California Institute of Technology; B.S. in Chemistry from Oklahoma Baptist University.
Field of Expertise
Healthcare & Life Sciences - Biology
Sector of Economy
Healthcare
Born
September 9, 1957 - 68 years ago
CEO of Pacific Biosciences of California for
8 years 11 months (Jan 2012 - Dec 2020)
Previous Experience
General Partner at Alloy Ventures, Venture Capital Firm; 21 years at Applied Biosystems in various positions, including president and general manager.
Other Pacific Biosciences of California CEOs
Holdings
Track Michael Hunkapiller's stock holdings and portfolio value over time.
Total Stock Sold
$141.86M
$141.86M
7,042,889 PACB shares
What if they kept their stock?
If Michael Hunkapiller didn't sell their stock, today they would have:
Extra PACB7,042,889 shares worth $15.28M.
This is -89.23% and $126.58M less than what they got when they sold the stock.
Insider Trading
Michael Hunkapiller's recent stock transactions, purchases, and sales filed with the SEC.
$7.51M
PACB at $32.06/share
Feb 26, 2021
Sale
$21.10M
PACB at $34.83/share
Feb 24, 2021
Sale
$21.76M
PACB at $36.12/share
Feb 22, 2021
Sale
$4.58M
PACB at $36.53/share
Jan 25, 2021
Sale
$23.65M
PACB at $37.87/share
Jan 20, 2021
Sale
$16.72M
PACB at $23.88/share
Dec 21, 2020
Sale
$21.46K
PACB at $14.39/share
Nov 24, 2020
Sale
$6.02M
PACB at $15.07/share
Nov 20, 2020
Sale
$634.32K
PACB at $15.63/share
Nov 18, 2020
Sale
$675.35K
PACB at $15.90/share
Nov 16, 2020
Sale
Rivals
Compare Michael Hunkapiller with competitor CEOs and industry peers.